Stock Track | DaVita HealthCare Partners Soars 22.55% Intraday on Strong Q1 Earnings Beat and Raised Full-Year Guidance

Stock Track05-07

DaVita HealthCare Partners' stock soared 22.55% during Wednesday's trading session, driven by the company's robust first-quarter financial results and upward revision of its annual profit forecast.

The kidney dialysis service provider reported adjusted earnings per share of $2.87 for the quarter, significantly surpassing the analyst consensus estimate of $2.32. Quarterly revenue reached $3.42 billion, also exceeding market expectations of $3.36 billion. Furthermore, DaVita raised its full-year 2026 adjusted EPS guidance to a range of $14.10 to $15.20, up from its previous outlook of $13.60 to $15.00.

The strong performance and improved outlook, attributed to steady demand for its services and operational execution, prompted positive analyst reactions, including an upgrade to Buy from Hold by Deutsche Bank and a target price increase to $220 from $126.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1121082361?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-07 03:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1121082361","market":"nz","top_or_hot":-1,"title":"Stock Track | DaVita HealthCare Partners Soars 22.55% Intraday on Strong Q1 Earnings Beat and Raised Full-Year Guidance","media":"Stock Track","content":"<p>DaVita HealthCare Partners' stock soared 22.55% during Wednesday's trading session, driven by the company's robust first-quarter financial results and upward revision of its annual profit forecast.</p><p>The kidney dialysis service provider reported adjusted earnings per share of $2.87 for the quarter, significantly surpassing the analyst consensus estimate of $2.32. Quarterly revenue reached $3.42 billion, also exceeding market expectations of $3.36 billion. Furthermore, DaVita raised its full-year 2026 adjusted EPS guidance to a range of $14.10 to $15.20, up from its previous outlook of $13.60 to $15.00.</p><p>The strong performance and improved outlook, attributed to steady demand for its services and operational execution, prompted positive analyst reactions, including an upgrade to Buy from Hold by Deutsche Bank and a target price increase to $220 from $126.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | DaVita HealthCare Partners Soars 22.55% Intraday on Strong Q1 Earnings Beat and Raised Full-Year Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | DaVita HealthCare Partners Soars 22.55% Intraday on Strong Q1 Earnings Beat and Raised Full-Year Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-07 03:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>DaVita HealthCare Partners' stock soared 22.55% during Wednesday's trading session, driven by the company's robust first-quarter financial results and upward revision of its annual profit forecast.</p><p>The kidney dialysis service provider reported adjusted earnings per share of $2.87 for the quarter, significantly surpassing the analyst consensus estimate of $2.32. Quarterly revenue reached $3.42 billion, also exceeding market expectations of $3.36 billion. Furthermore, DaVita raised its full-year 2026 adjusted EPS guidance to a range of $14.10 to $15.20, up from its previous outlook of $13.60 to $15.00.</p><p>The strong performance and improved outlook, attributed to steady demand for its services and operational execution, prompted positive analyst reactions, including an upgrade to Buy from Hold by Deutsche Bank and a target price increase to $220 from $126.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DVA","symbol_name":"达维塔保健","start_time":0,"source_url":"","article_id":"1121082361","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1121082361","pubTimestamp":1778096583,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"DaVita HealthCare Partners' stock soared 22.55% during Wednesday's trading session, driven by the company's robust first-quarter financial results and upward revision of its annual profit...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DVA":"达维塔保健"},"translate_title":"个股追踪|DaVita HealthCare Partners盘中飙升22.55%，因Q1盈利强劲超出预期并上调全年指引","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DVA":1},"content_text":"DaVita HealthCare Partners' stock soared 22.55% during Wednesday's trading session, driven by the company's robust first-quarter financial results and upward revision of its annual profit forecast.The kidney dialysis service provider reported adjusted earnings per share of $2.87 for the quarter, significantly surpassing the analyst consensus estimate of $2.32. Quarterly revenue reached $3.42 billion, also exceeding market expectations of $3.36 billion. Furthermore, DaVita raised its full-year 2026 adjusted EPS guidance to a range of $14.10 to $15.20, up from its previous outlook of $13.60 to $15.00.The strong performance and improved outlook, attributed to steady demand for its services and operational execution, prompted positive analyst reactions, including an upgrade to Buy from Hold by Deutsche Bank and a target price increase to $220 from $126.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1121082361","isCrawlerRequest":true}